Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as an Add-on to Metformin, Thiazolidinediones, or Both, in Patients With Type 2 Diabetes (SUSTAIN 2): A 56-Week, Double-Blind, Phase 3a, Randomised Trial
Time will tell if the bull market in Europe has more legs to outrun the U.S
Organ transplant recipients on immunosuppressants like cyclosporine
Track what matters and achieve the results you deserve from your semaglutide therapy
[Laughs.] And reta, big phase 2 results came out for that in 2023
The side effects reported most often with Wegovy are gastrointestinalnausea, vomiting, and constipation